New small-cell lung cancer therapy studied
Tuesday, June 2, 2009 - 14:35
in Health & Medicine
NEW YORK, June 2 (UPI) -- A U.S.-led international study suggests the combination of two drugs can delay disease progression for patients with advanced non-small cell lung cancer.
Read the whole article on UPI
More from UPI
Related
- Study shows drug combination improves outcome for advanced non-small cell lung cancerSat, 30 May 2009, 11:29:37 EDT
- Advanced lung cancer patients see improved, progression-free survivalThu, 13 Nov 2008, 10:51:04 EST
- Vandetanib shows clinical benefit when combined with docetaxel for lung cancerMon, 1 Jun 2009, 9:44:28 EDT
- Fox Chase finds all-biologic regimen efficacious and well-tolerated in elderly lung cancer patientsSat, 1 Aug 2009, 15:37:16 EDT
- Fox Chase finds that lung cancer patients respond to erlotinib following cetuximab therapySat, 1 Aug 2009, 15:37:20 EDT